They haven't made progress on cancer treatment for 10 years. What makes you think they will now that Slilaty is nearing retirement age?

They are tweeting about nutritional supplements... What a joke.

Can't wait to hear how all the long term pumpers try and spin this absolute shady style of dilution. They absolutely pull out all the crafty and slimy ways of wording things to maximize massive amounts of dilution.

From doubling the ratio of their reverse split at the last second from 1:100 to 1:200 to get on Nasdaq to packaging 2 exercisable warrants with every share on the initial offering to saying they won't issue new shares for 6 months then immediately completing an "offering" which functionally adds 10 million more shares to the OS, the pumpers have plenty of BS to sling because long term shareholders are up to their necks in it. And yet, I get a feeling these long term pumpers will talk about how this is a good thing in the long run, because there is absolutely no way it's going to do anything for the share price.

Major scam going on here.

Most likely. They can't expect that these BS patent filing PRs are going to jump the price they way they did on the OTC. They need actual progress on anything in order to get out of the gutter that is the current share price.

Apparently longer than 10 years if you go by the blind enthusiasm some on this board have.

Right because the COVID vaccine is so effective

It's fluff because they have released this nonsense for over 10 years "non-toxic cancer killing compound patent filed/obtained"


2012: IND studies started for already proven cancer-killing compound adva-27a
https://www.bioprocessonline.com/doc/sunshine-biopharma-initiates-enabling-studies-anticancer-adva-0001

2014: expands to test on pancreatic cancer, well over a year later, still no further testing beyond pre-clinical
https://www.biospace.com/article/releases/sunshine-biopharma-inc-targets-pancreatic-cancer-as-second-indication-for-clinical-trials-of-adva-27a-compound-/

2016: states they intend to start phase 1 clinical trials, this is 6 years ago and they still haven't started phase 1 human trials, even though they had the intent back then.
https://money.cnn.com/news/newsfeeds/articles/marketwire/1239886.htm

Then come the 20:1 reverse splits in consecutive years, 2019 and 2020. Surely if they had such an amazing drug someone would have funded them in that 3-4 year span from 2016 to 2020 so they wouldn't have to reverse split the stock twice. Oh and of course a 200:1 reverse split this past year to make it to the Nasdaq.

Why haven't they been able to get to phase 1 trials, something they have planned to do since 2012, yet still have not achieved a decade later. Now all of a sudden they throw a new buzzword like mRNA on top of their old compound effective at killing cancer in a petri dish and people think something new will happen? They also jumped on the COVID craze to capitalize on investors. Whatever happened with their COVID treatment that started mice testing in February 2021? No word on that.

Until they actually release a PR stating they have officially begun phase 1 testing, all PRs are fluff because they have been virtually saying the same thing for 10 years.

He's good at that, and at making up nonsense that you never said to pretend he is discrediting your point.

Retail shareholders aren't going to do shit to the share price, so ihub posts that you think are designed to create FUD are useless. Just ask some of the most blindly positive pumpers on this board, they've used the line that nothing anyone says on here will do anything to affect the share price.

We will see, they have been trading way too many shares in the past couple of weeks to be so low, imo.

Exactly, they can't have traded at the volumes over the past week or two with the outstanding shares they have currently listed. The sbfmw warrants still haven't been accounted for in the OS.

You are missing the warrants that have yet to be added back in from that BS offering of shares with two packaged warrants per share, it will be in the 20-30mil range

Not to mention it's click bait title about clinical trials when clinical trials aren't even mentioned in the actual article

It's a pump piece with a click bait title. They don't mention anything about actual clinical results and they say it can regain the high of $10, when this was trading at $18 (which is still way down from previous highs when you figure in the 200:1 reverse split). Shoddy info and a misleading article title show this is a pump article, and not a very good one.

Funnier than this joke of a stock

Wow really proving a point that this company hasn't made any progress on cancer research in a decade by posting a reprint of an article from 2011...

e.com/fr/news-release/2011/07/27/452309/16231/en/Sunshine-Biopharma-Looking-to-Mimic-Roche-s-Billion-Dollar-Cancer-Drug-Success.html

Yep we shall. So far this company has 10 years of no follow through and Slilaty is in his 70s and just got paid $360k annually for the next 4 years and if he quits with a valid reason he gets $10 million. He is easily at the age where retirement is a valid reason. Would not be surprised to see him cash out soon

Been hearing "news next week!" for well over a year now. It's the mating call of the ihub hopium addicts

They have no news, it's why they recycle old information with a new spin of the buzzword of the year: mRNA.
Before that it was suddenly they have a COVID treatment that they never announced mice results from, which were started in February of last year.

This is exactly what I have been saying. They release the same news about destroying cancer cells and how they anticipate going to phase 1 trials in 9-18 months. They have been saying that for 10 years now

And ihub boards are like shady casinos full of people who are convinced they are about to hit their big lucky break. I hear the same thing every day, every week "this is going to blow up." Been hearing it for over a year now and they haven't done anything. Whatever happened to the mice trial results for COVID and adva-27a? Guess they just don't have anything to report. It was always, " oh waiting for uplist, waiting for quiet period to end...".

What's the next excuse?

Exactly, nothing has changed with the science for 10 years, which is why they never release mice trial results or progress past them.

This is nothing new...

They have also been planning on going to phase 1 human trials for their cancer drug for 10 years

If that were the case I would rarely leave this board.

What is it, 3 good days in the last 10 months of a slow downward spiral and a surprise 1:200 reverse split, with 2 warrants offered alongside a public offering that now effectively reduced the share value by a factor of 3? And what people are excited because it jumped 40% consecutive days to not even reach $10 per share, which is effectively a $0.05 share value pre split. Any true longs know that that was the low share price for the better part of the last year. So if you are excited about where things are at now you've definitely been flipping and pumping. But that's nothing new here.

Never left

What's old hat is this company releasing PRs stating their compound is effective at killing cancer. They've been releasing that PR for 10 years and have never made it past mice trials.

(edit - typo)

Let's see them actually get to phase 1 trials before we start talking big money. This company has consistently promised intentions to go to phase 1 trials over the past 10 years.

Furthermore, the announcement of arresting cancer in cells is no new claim from this company's cancer treatment, that's what adva-27a has been claimed to do for years in pre-clinical. The only thing different is that they infused the PER with mRNA technology to achieve something they supposedly had been capable of 10 years ago with adva-27a. So there is really nothing new here except an old hat dressed up with a new feather in it.

Also it says 9-18 months before they even expect to get to Phase 1 trials. Pfizer and Moderna lobbied for fast track for COVID vaccines and they don't even hardly work at preventing getting or spreading COVID. Slilaty is in his 70s, the company has said time and again the success of the company rides on his coattails and a year or more before even phase 1 trials? Sorry it's a PR ploy with the same old promises and 10 years of evidence that the company never progresses past mice trials.

They never have released any kind of news that was more than tip of the iceberg. First it's COVID nice trials, then cancer mice trials, then preclinical possibility of neurological treatments, then mRNA toxicity in pre-clinicals. Oh and they have been saying for 10 years they anticipate phase 1 testing to begin for cancer treatment. Still in pre-clinicals. Pump then dump for 10 years

It was a joke

What are you talking about they are constantly putting out PRs about how important dietary supplements are. They are going to be major players in the nutritional supplement game. That's why Aegis invested, that's why they have consistently been pumping out PRs on their website about nutritional supplements. Let's gooooooooooooooooo!!!!!!!

Please the pumpers here move the goal posts all the time. I remember back when they first announced COVID mice trials everyone was saying we would get results within a week or a month. Still no results to this day more than a year later.

Then it was the reverse split won't happen because they will release news that will explode the share price and the r/s won't be necessary. Boom 200:1 reverse split goes through.

Now you are saying they expect the fast track approval. Well guess what, they have been saying for 10 years that they anticipate moving adva-27a to phase 1 human testing, and this has been in 10q's and 8k's so they have no problem officially releasing something with the words anticipate and never having that anticipated result come to fruition. This is a company that always promises tomorrow and then sells today.

Here's a list of PRs over the years:
https://fintel.io/sf/us/sbfm

Here's a link to one from 2013 10k:
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-10k-2013-march-15-18759-274

"We anticipate that the clinical trials will be completed by late 2015" pg 7 in the Clinical Trials section

Then you have this 10k from 2015:
https://fintel.io/doc/sec-sunshine-biopharma-inc-1402328-10k-2015-march-11-18759-438

On page 6, last sentence of the page under Clinical trials, it reads :
"As a result of the Dutchess Agreement and other financing opportunities described below, we now anticipate that Phase I clinical trials will commence in mid to late 2016 and we estimate that it will take 18 months to complete, at which time we expect to file for limited marketing approval with the regulatory authorities in Canada and the FDA in the U.S."

Does that language sound familiar???

18 months to complete phase 1 clinical trials and they expect them to start in 2016. Hmmm what happened? What keeps happening?

Yeah as soon as I saw the fuckery with the R/S ratio I knew it was time to take profits that I could live with and roll the dice on the rest

I'm well aware, held for over a year and got my initial investment back with some profit before they pulled the R/S shenanigans. Holding some in case they actually have anything legit, but I took my profits and am fine with that if that is all it turns out to be.

Yeah plenty of people on here 'truly believed' a lot of BS over the past couple years and almost none of it happened. Only thing that did happen was they made it to Nasdaq. But I heard how we would have mice trials results over a year ago, we wouldn't do a reverse split to get on nasdaq and if we did it would be after news and 1:20 at most. I heard we were on fast track for over a year and I've heard the 'big news any day now' for well over a year and NONE of it has happened. Just a bunch of bullsh**ters on here.

I still hold shares, but I don't have much in the way of expectation. I hope I am wrong, but this company has not shown much of anything other than empty promises.

Yeah and they got $8 million on the Aegis offer when they were looking for $20 million, and sold the lie that they were going to get $20 million to shareholders right before they did a bait and switch and immediately reverse split at a new conversion rate of 1:200 on almost no notice.

Now there is a supposed waiting period and when that comes and goes with no real news (i.e. mice results on adva-27a and/or sbfm-pl4, or phase one on either or both, any other news is an admittance that those were both failures) I will be interested to see what all the pumpers make up as the next fake bench mark that we should all hold for.

Nah, this stuff means nothing if the company doesn't have actual news.

Uh, no infact I have a very good idea because I do freelance writing on the side and have many friends that do it as a full time gig and it's literally just a paycheck to them. They are advertisers running copy for whatever publication hires them to write a piece. Welcome to the new world of gig economy and freelancers.

Are you serious? She is a freelance writer. You literally pay them to write pieces for you. That's specifically what their job is, to write what you pay them to write.

Besides, Benzinga is utter trash.